Skip to content

The FASEB Journal

ISSN 0892-6638, 1530-6860

63 papers in the library · 234 citations · publishing 1997-2025

Papers

Sort Most recent Most cited

Effects of serotonergic hallucinogen R (−)‐2,5‐Dimethoxy‐4‐iodoamphetamine (DOI) on temporal discrimination in mice

The FASEB Journal April 1, 2017 Michael P Trahan, Sebastian Leth-Petersen, William E Fantegrossi

R (−)‐2,5‐Dimethoxy‐4‐iodoamphetamine (DOI) and other compounds with agonist affinity for serotonergic 5‐HT2A receptors are hallucinogenic drugs of abuse, but also have therapeutic potential in numerous neuropsychiatric conditions, including major depressive disorder, post‐traumatic stress disorder, and in the treatment of migraine and cluster headaches. Thus, commonly abused hallucinogens...

Antidepressant‐like Effects of Ketamine in Serotonin Transporter Knockout Mice and Organic Cation Transporter 3 Knockout Mice

The FASEB Journal April 1, 2017 Melodi Ann Bowman, Melissa Vitela, W. Anthony Owens et al.

Twenty percent of adults are diagnosed with major depressive disorder, which is typically treated with selective serotonin reuptake inhibitors. However, this type of medication takes approximately six weeks to produce therapeutic effects. Recently, low doses of ketamine, a noncompetitive N‐methyl‐D‐aspartate (NMDA) receptor antagonist, have been shown to produce rapid and long‐lasting...

Psychedelics Produce Complex And Heterogeneous Transcriptional Responses In Diverse Cortical Cell Types In The Brain Of Rats As Determined By New Flow Cytometric Methods Allowing For Sorting Of Distinct Cell And Neuronal Populations From Whole Brain

The FASEB Journal April 1, 2016 David Martin, Connie Porretta, Charles D. Nichols 1 citation

Psychedelics, also known as classic serotonin hallucinogens, are currently being investigated by several groups for their potential as therapeutic agents for a variety of psychiatric indications. Although the neural circuitry underlying the effects of psychedelics is being established by others, the role of specific cell types and populations within the brain that respond to these agents remain...

DOI: 10.1096/fasebj.30.1_supplement.930.3 (opens in new tab) Parvalbumin Cell type Flow cytometry Cerebral cortex +4

Lysergic Acid Diethylamide (LSD) Modulates Circadian Activity Behavior And The Expression Level of Circadian Genes in Drosophila melanogaster in Both Sexes

The FASEB Journal April 1, 2016 Kelly Jean Sherman, Charles D. Nichols

Circadian rhythms modulate biochemical and molecular pathways in living systems. In humans an endogenous clock mechanism is synchronized by a daily light‐dark cycle: sun up and sun down. These external cues from the environment regulate the core‐clock through auto‐regulating circadian genes’ expression levels. These oscillating gene products modulate physiological, biochemical, and molecular...

DOI: 10.1096/fasebj.30.1_supplement.930.4 (opens in new tab) Serotonin Circadian rhythm Circadian clock Drosophila melanogaster +5

The Effects of Δ 9 ‐Tetrahydrocannabinol (THC) Drug History on THC Taste and Place Conditioning

The FASEB Journal April 1, 2016 Briana J. Hempel, Alison Wakeford, Matthew M Clasen et al.

Rationale Δ 9 ‐Tetrahydrocannabinol (THC) produces both aversive and rewarding effects in animal models. Given that the balance between a drug's affective properties is thought to underlie its abuse potential, it is important to consider these properties of THC and how they (and their balance) are impacted by various factors. In this context, previous studies have examined the effect of THC...

Methylation of Thiols and Thioethers by Human Indolethylamine‐N Methyl Transferase

The FASEB Journal April 1, 2015 Uyen Bao Chu, Timur A. Mavlyutov, Amanda Schulman et al. 10 citations

Indolethylamine‐N MethylTransferase (INMT) is a small molecule N‐methyltransferase that transfer methyl groups from S‐Adenosyl‐L‐Methionine (SAM) to indoleamines. Methylation of tryptamine produces the hallucinogen, N,N‐dimethyltryptamine (DMT), and methylated serotonin generates bufotenin. In animals, the endogenous production of DMT has been proposed to be a regulator of the Sigma‐1 Receptor...

Noribogaine is a Mixed Agonist/Antagonist Opioid Ligand with Profound Functional Selectivity

The FASEB Journal April 1, 2015 Émeline L. Maillet, Nicolas Milon, James A. Fishback et al. 1 citation

Noribogaine is the primary metabolite of the anti‐addictive substance ibogaine, which modulates opiate analgesic activity and the components of drug addiction in animal models at brain concentrations of 0.5‐15 µM. In this study, molecular activities of noribogaine at mu (OPRM) and kappa (OPRK) opioid receptors were characterized. Noribogaine was a moderately potent antagonist of the OPRM...

DOI: 10.1096/fasebj.29.1_supplement.lb505 (opens in new tab) Antagonist Pharmacology Functional selectivity Partial agonist +8

Hallucinogens Activate a Specific Population of Neurons in the Cortex

The FASEB Journal April 1, 2015 David Martin, Connie Porretta, Charles D. Nichols 1 citation

Serotonin hallucinogens produce a range of cognitive, sensory, and emotional effects in man. Recently, a resurgence of clinical interest in these compounds has developed because they can produce pronounced and long‐lasting psychological changes. While the structural backbones and receptor pharmacology of hallucinogens vary, their primary effects arise from agonism of the 5‐HT 2A receptor....

DOI: 10.1096/fasebj.29.1_supplement.931.14 (opens in new tab) Hallucinogen Somatosensory system Population Fosb +5

Characterization of Noribogaine at nAChRs and Effect on Nicotine Self‐Administration in Rats

The FASEB Journal April 1, 2015 Émeline L. Maillet, Qing Chang, Nicolas Milon et al.

Noribogaine, a polypharmacological drug with activities at opioid receptors, ionotropic nicotinic receptors, and serotonin reuptake transporters, is being investigated for treatment of substance abuse‐related disorders. In this study, noribogaine molecular activity at neuronal nicotinic acetylcholine receptors (nAChRs) was characterized. Noribogaine inhibited α3β4, α7 nAChRs, and endogenously...

DOI: 10.1096/fasebj.29.1_supplement.1019.2 (opens in new tab) Varenicline Pharmacology Nicotine Nicotinic agonist +4

Effects of 3,4‐Methylenedioxypyrovalerone (MDPV) and 3,4‐Methylenedioxymethamphetamine (MDMA) on Place Conditioning in Mice

The FASEB Journal April 1, 2015 Brenda M. Gannon, Julia Tobacyk, William E Fantegrossi

Recently, there has been an increase in abuse of new synthetic psychostimulant drugs derived from the cathinone structure. These products are typically referred to as “bath salts”, and one of the most common psychoactive constituents of these preparations is 3,4‐methylenedioxypyrovalerone (MDPV). In these studies, we used the conditioned place preference (CPP) paradigm to explore the apparent...

Humor similar to meditation enhances EEG power spectral density of gamma wave band activity (31‐40Hz) and synchrony (684.5)

The FASEB Journal April 1, 2014 Lee Berk, Clarice Alphonso, Neha Thakker et al.

Humor associated mirthful laughter (HAML) similar to meditation, both positive brain states, have complex mental processes that can modulate emotions, cognition, memory, sensory perception, consciousness, hormones, immune, and CNS activity. Meditation is used as a non‐pharmacological lifestyle intervention to provide health benefits, from promoting wellness to alleviating symptoms of a variety...

Discriminative‐stimulus effects of 3,4‐methylenedioxy‐N‐methylamphetamine (MDMA) and a novel MDMA quatenary analog

The FASEB Journal April 1, 2013 Jonathan M. Slezak, Melanie Mueller, George A. Ricaurte et al.

MDMA (ecstasy), popularized as a “club drug,” is a psychoactive and abused substance. It is often assumed that the behavioral effects of MDMA are due to central actions, though this has not been tested. Using a quaternary analog of MDMA (qMDMA) we tested that assumption by training male Sprague‐Dawley rats (n = 6) to discriminate intraperitoneal (i.p.) injections of 1.7 mg/kg of MDMA HCl from...

The discriminative stimulus effects of nitrous oxide in B6SJLF1/J mice

The FASEB Journal April 1, 2013 Kellianne J. Richardson, Keith L Shelton

The abuse‐related CNS effects of nitrous oxide (N 2 O) are poorly understood. In vitro data suggests that N 2 O alters the function of NMDA and GABA A receptors, amongst others. Our goal was to assess the neurotransmitter systems responsible for producing the intoxicating effects of N 2 O using drug discrimination. Twenty‐four mice were trained to discriminate 10 min of exposure to 60% N 2...

Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiology

The FASEB Journal April 1, 2012 Evan J. Kyzar, Christopher Collins, Jeremy Green et al. 1 citation

Mescaline, phencyclidine (PCP) and psilocybin are potent hallucinogenic drugs strongly affecting both human and animal behavior. However, these compounds have not been previously investigated in zebrafish (Danio rerio), rapidly gaining popularity as a model in psychopharmacology research. Here, we examine the effects of mescaline, PCP and psilocybin in multiple behavioral paradigms. Mescaline...

Pharmacokinetic and pharmacodynamic interactions of indolealkylamine drugs of abuse

The FASEB Journal April 1, 2012 Ai-Ming Yu

Indolealkylamine (IAA) drugs are a major class of serotonin analogs that have high impact as substances of abuse. Among them, 5‐methoxy‐ N,N ‐dimethyltryptamine (5‐MeO‐DMT) was placed into Schedule I controlled substance status in the United States as of January 19, 2011, which is often co‐abused with harmaline. IAA drugs acts mainly on the serotonin neurotransmission system. Overdose of one...

DOI: 10.1096/fasebj.26.1_supplement.849.2 (opens in new tab) Serotonin Harmaline Pharmacology Monoamine oxidase +3

Chronic LSD administration produces changes in mPFC gene and protein expression relevant to schizophrenia, as determined by RNA‐Seq and DIGE

The FASEB Journal April 1, 2012 David Martin, David E. Nichols, Charles D. Nichols

The objective of this work is to characterize genetic and proteomic changes in a novel rat model of schizophrenia. Three‐month treatment with low doses of the hallucinogenic drug, LSD, induces a range of abnormal behaviors including social deficits, hyperactivity, and anhedonia. These behavioral changes persist in the absence of drug , and likely result from neuroadaptive changes in the medial...

DOI: 10.1096/fasebj.26.1_supplement.1044.6 (opens in new tab) Prefrontal cortex Schizophrenia object-oriented programming Anhedonia Gene expression +3

Interaction of ibogaine with human a3b4 nicotinic receptors in different conformational states

The FASEB Journal April 1, 2012 Ilana Emert, Katarzyna M Targowska-Duda, Dominik Feuerbach et al.

The interaction of ibogaine and phencyclidine (PCP) with human (h) α3β4 nicotinic acetylcholine receptors (AChRs) in different conformational states was determined using radioligand binding assays, Ca 2+ influx detections, thermodynamic and kinetic measurements. The results show that ibogaine inhibits (±)‐epibatidine‐induced Ca 2+ influx in hα3β4 AChRs with ~9‐fold higher potency than PCP, [ 3...

DOI: 10.1096/fasebj.26.1_supplement.762.1 (opens in new tab) Phencyclidine Nicotinic acetylcholine receptor Nicotinic agonist Stereochemistry +7

Pro‐social effects of 3,4‐methylenedioxymethamphetamine in mice

The FASEB Journal April 1, 2012 Daniel Walker Curry, Kevin Sean Murnane, Leonard Lee Howell

The drug 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) has been shown to increase feelings of closeness and empathy in humans. Despite evidence of MDMA‐induced neurotoxicity, these unusual pro‐social effects have continued to generate interest in the drug's therapeutic potential. Therefore, determining the mechanisms by which MDMA engenders these effects may allow for the development of...

Exploring The Molecular Mechanisms Underlying The Efficacy of Mindfulness Based Stress Reduction In Alleviating Psychological Stress in Alzheimer's Disease Caregivers

The FASEB Journal April 1, 2012 Lap Ho, Patricia A. Bloom, Joan Griffiths Vega et al.

Caregiving for a dementia patient is associated with an increased risk for emotional distress, depression, dementia, physical health problems and death. Targeting caregivers as the recipients of interventions may greatly improve patient care. Mindfulness Based Stress Reduction (MBSR) is a clinical intervention based on simple meditation practices which have been shown to reduce stress and...

Antidepressant‐like effect of AMPA and ketamine combination in male Wistar ‐Kyoto rats

The FASEB Journal April 1, 2012 Luli R Akinfiresoye, D. M. Lovinger, Y. Tizabi

Studies have shown that therapeutics that act on the glutamatergic system could provide a novel mechanistic approach for the treatment of depression. We previously reported that ketamine, an NMDA antagonist, has a rapid and lasting antidepressant effect both acutely and chronically on depressive‐like behavior in Wistar‐Kyoto (WKY) rats ( Soc Neurosci Abst 2008) . Other studies had suggested...

Antagonism of 5‐HT2A receptors attenuates the effects of amphetamine and 3,4‐methylenedioxymethamphetamine on wakefulness and dopamine overflow

The FASEB Journal April 1, 2012 Kevin Sean Murnane, Leonard Lee Howell

The neuropharmacology of the sleep and arousal systems involves a complex interplay between multiple neurotransmitter systems. Previous work has downplayed the role of dopamine in sleep and wakefulness, at least in part, because dopamine neurons do not appear to change their firing rates across arousal states. In the present study, we examined the wake promoting effects of amphetamine and...

Acute effects of d‐methamphetamine, 3,4‐methylenedioxypyrovalerone, 3,4‐methylenedioxymethamphetamine, and 4‐methylmethcathinone on wheel activity in rats

The FASEB Journal April 1, 2012 Pai-Kai Huang, Shawn. M. Aarde, Tobin J. Dickerson et al.

A recent DEA report and ongoing media accounts show increasing recreational use of 4‐methylmethcathinone (4‐MMC, mephedrone) and 3,4‐methylenedioxypyrovalerone (MDPV). Some severe sympathomimetic symptoms, hallucinations, psychoses, and even deaths have been reported. Recent studies showed that 4‐MMC and MDPV enhanced DA neurotransmission, while 4‐MMC also increased 5‐HT neurotransmission, much...

Effects of 3,4‐methylenedioxymethamphetamine (MDMA) and its metabolites on cardiovascular function in rats

The FASEB Journal April 1, 2012 Charles W. Schindler, Michael H Baumann, Eric B. Thorndike et al.

The abuse of MDMA (Ecstasy) peaked in the early 2000s, yet reports of MDMA use from emergency room admission data continue to increase. The potential for cardiovascular effects of MDMA to contribute to its acute toxicity has long been recognized. However, the role of MDMA metabolites in mediating the drug's cardiovascular actions has not been studied. Here we employed radiotelemetry to evaluate...

Emergent pharmacology of conscious experience: new perspectives in substance addiction.

The FASEB Journal July 1, 2011 Jean-Pierre Changeux, Hans C Lou

We here review experimental findings relevant for the pharmacology of conscious experience, an issue largely neglected in pharmacological research. First, we focus on self-awareness, a pivotal component of conscious experience and its integration within the global neuronal network (GNW), a theoretical concept that unifies convergent approaches on the neural bases of conscious processing. We...

3D‐based analyses of pharmacological modulation of zebrafish locomotion

The FASEB Journal April 1, 2011 Jonathan Cachat, Russell Reihl, Jessica Cosgrove et al. 1 citation

Here, we integrated manual observations, computerized event‐based scoring and automated video analysis of zebrafish traces to generate three‐dimensional (3D) swim path reconstruction of general behavioral patterns, thereby improving the characterization and interpretation of complex, anxiety‐related adult zebrafish behavior. Drugs known to evoke a high‐anxiety state (caffeine, repeated morphine...